Therapy with tyrosine kinase inhibitor lenvatinib in radioactive iodine-naive advanced differentiated thyroid cancer

被引：2
|
作者：
Sukumar, Jasmine Singh [1 ,2 ]
Moore, William [3 ]
Khan, Saad A. [4 ,5 ,6 ]
机构：
[1] Ohio State Univ, Med Ctr, Div Hematol, Columbus, OH 43210 USA
[2] Ohio State Univ, Med Ctr, Div Med Oncol, Columbus, OH 43210 USA
[3] UT Southwestern Med Ctr, Dept Radiol, Dallas, TX 75390 USA
[4] UT Southwestern Dept Internal Med, Dallas, TX 75390 USA
[5] Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
[6] UT Southwestern Med Ctr, Dallas, TX 75390 USA
来源：
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY | 2019年 / 6卷 / 04期
关键词：
differentiated thyroid cancer; lenvatinib; papillary thyroid cancer; radioactive iodine-naive; tyrosine kinase inhibitor; MANAGEMENT;
D O I：
10.2217/ije-2019-0007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Lenvatinib in multimodal therapy for unresectable radioactive iodine-naive differentiated thyroid cancer: A case report with literature review
    Kim, Hugh Andrew Jinwook
    Nichols, Anthony Charles
    Rachakonda, Ramanamurthy
    Inculet, Richard
    Sathya, Jinka
    Rachinsky, Irina
    Winquist, Eric
    [J]. CANCER REPORTS, 2022, 5 (10)
  • [2] Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
    Cortas, Christos
    Charalambous, Haris
    [J]. LIFE-BASEL, 2024, 14 (01):
  • [3] Tyrosine kinase inhibitor therapy in a case of locally advanced differentiated thyroid cancer
    Stewart, Kirsten
    Strachan, Mark
    Srinivasan, Dev
    MacNeill, Morna
    Wall, Lucy
    Nixon, Iain
    [J]. BRITISH JOURNAL OF SURGERY, 2019, 106 : 14 - 14
  • [4] Lenvatinib in Advanced, Radioactive Iodine-Refractory, Differentiated Thyroid Carcinoma
    Yeung, Kay T.
    Cohen, Ezra E. W.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5420 - 5426
  • [5] Clinical factors related to the efficacy of tyrosine kinase inhibitor therapy in radioactive iodine refractory recurrent differentiated thyroid cancer patients
    Sugino, Kiminori
    Nagahama, Mitsuji
    Kitagawa, Wataru
    Ohkuwa, Keiko
    Uruno, Takashi
    Matsuzu, Kenichi
    Suzuki, Akifumi
    Masaki, Chie
    Akaishi, Junko
    Hames, Kiyomi Y.
    Tomoda, Chisato
    Ogimi, Yuna
    Ito, Koichi
    [J]. ENDOCRINE JOURNAL, 2018, 65 (03) : 299 - 306
  • [6] Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a series
    Stewart, Kirsten E.
    Strachan, Mark W. J.
    Srinivasan, Devraj
    MacNeill, Morna
    Wall, Lucy
    Nixon, Iain J.
    [J]. BRITISH JOURNAL OF SURGERY, 2022, 109
  • [7] Tyrosine Kinase Inhibitor Therapy in Locally Advanced Differentiated Thyroid Cancer: A Case Report
    Stewart, Kirsten E.
    Strachan, Mark W. J.
    Srinivasan, Devraj
    MacNeill, Morna
    Wall, Lucy
    Nixon, Iain J.
    [J]. EUROPEAN THYROID JOURNAL, 2019, 8 (02) : 102 - 107
  • [8] Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer
    Capdevila, Jaume
    Newbold, Kate
    Licitra, Lisa
    Popovtzer, Axon
    Moreso, Francesc
    Zamorano, Jose
    Kreissl, Michael
    Aller, Javier
    Grande, Enrique
    [J]. CANCER TREATMENT REVIEWS, 2018, 69 : 164 - 176
  • [9] Radioactive iodine therapy in poorly differentiated thyroid cancer
    R Michael Tuttle
    Ravinder K Grewal
    Steve M Larson
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 665 - 668
  • [10] Radioactive iodine therapy in poorly differentiated thyroid cancer
    Tuttle, R. Michael
    Grewal, Ravinder K.
    Larson, Steve M.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 665 - 668
12345